Literature DB >> 17874221

Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.

K-C Hsueh1, Y-J Lin, J-S Chang, L Wan, Y-H Tsai, C-H Tsai, C-P Chen, F-J Tsai.   

Abstract

High expression of circulating vascular endothelial growth factor (VEGF) has been reported in patients with Kawasaki disease (KD). In the pathophysiology of KD, VEGF is considered to be involved, especially in the development of coronary artery lesions. This study aimed to examine whether the VEGF-634 promoter polymorphism is a marker of KD susceptibility or severity in Chinese patients in Taiwan. The study included 93 KD patients and 96 normal control subjects. Genotype and allelic frequencies for the VEGF gene polymorphism in the two groups were compared. The number of individuals with the VEGF-634 G/G genotype was significantly greater among the patients with KD than among the healthy control subjects (p = 0.011). The odds ratio for the development of KD in individuals with the VEGF-634 G/G genotype was found to be 2.03 (95% confidence interval [CI], 1.14-3.63) compared with the VEGF-634 G/C and VEGF-634 C/C genotypes. No significant difference was observed in the genotype or allelic frequencies of VEGF C-634 G polymorphism between the patients with and those without coronary artery lesions. In conclusion, the results suggest that VEGF-634 G/G genotype may be involved in the development of KD in Taiwanese children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874221     DOI: 10.1007/s00246-007-9049-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  28 in total

1.  Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.

Authors:  C J Watson; N J Webb; M J Bottomley; P E Brenchley
Journal:  Cytokine       Date:  2000-08       Impact factor: 3.861

2.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection.

Authors:  Majid Shahbazi; Anthony A Fryer; Vera Pravica; Iain J Brogan; Helen M Ramsay; Ian V Hutchinson; Paul N Harden
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.

Authors:  J Hirao; S Hibi; T Andoh; T Ichimura
Journal:  Int Arch Allergy Immunol       Date:  1997-02       Impact factor: 2.749

Review 4.  Kawasaki disease: infection, immunity and genetics.

Authors:  Chih-Lu Wang; Yu-Tsun Wu; Chieh-An Liu; Ho-Chang Kuo; Kuender D Yang
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

5.  A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

Authors:  W Renner; S Kotschan; C Hoffmann; B Obermayer-Pietsch; E Pilger
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

6.  Vascular endothelial growth factor in acute Kawasaki disease.

Authors:  M Terai; K Yasukawa; S Narumoto; S Tateno; S Oana; Y Kohno
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

7.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

8.  Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor.

Authors:  K Iijima; N Yoshikawa; D T Connolly; H Nakamura
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

9.  Increased serum levels of vascular endothelial growth factor in Kawasaki disease.

Authors:  N Maeno; S Takei; K Masuda; H Akaike; K Matsuo; I Kitajima; I Maruyama; K Miyata
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

10.  Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B Chiang
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

View more
  8 in total

1.  Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis.

Authors:  Ni Wei; Zijia Chen; Zhifeng Xue; Yuelan Zhu
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

Review 2.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

3.  Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children.

Authors:  Fu-Yuan Huang; Tzu-Yang Chang; Ming-Ren Chen; Hung-Chang Lee; Hsin Chi; Nan-Chang Chiu; Chyong-Hsin Hsu; Shuan-Pei Lin; Hsin-An Kao; Wei-Fang Chen; Hui-Wen Chan; Hsin-Fu Liu; Chen-Chung Chu; Marie Lin; Yann-Jinn Lee
Journal:  J Clin Immunol       Date:  2008-02-23       Impact factor: 8.317

Review 4.  Dissecting Kawasaki disease: a state-of-the-art review.

Authors:  S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers
Journal:  Eur J Pediatr       Date:  2017-06-27       Impact factor: 3.183

5.  Association between miRNA-196a2 rs11614913 T>C polymorphism and Kawasaki disease susceptibility in southern Chinese children.

Authors:  Jinxin Wang; Jiawen Li; Huixian Qiu; Lanlan Zeng; Hao Zheng; Xing Rong; Zhiyong Jiang; Xueping Gu; Xiaoqiong Gu; Maoping Chu
Journal:  J Clin Lab Anal       Date:  2019-05-26       Impact factor: 2.352

6.  KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis.

Authors:  Agnieszka Paradowska-Gorycka; Barbara Stypinska; Andrzej Pawlik; Damian Malinowski; Katarzyna Romanowska-Prochnicka; Malgorzata Manczak; Marzena Olesinska
Journal:  Biomolecules       Date:  2019-08-09

Review 7.  The role of infection in Kawasaki syndrome.

Authors:  Nicola Principi; Donato Rigante; Susanna Esposito
Journal:  J Infect       Date:  2013-04-18       Impact factor: 6.072

Review 8.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.